Tennessee HB 1917: Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.

Status: Effective date(s) 03/19/2020 (as of 2020-03-26)

State: Tennessee · Session: 111 · Bill: HB 1917

Subjects: Health Care

Sponsors: Reeves, Vaughan

View Tennessee HB 1917 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.